Get the Stockscreener App
4.26
11.80%
-0.57
Armata Pharmaceuticals Inc stock is traded at $4.26, with a volume of 244.46K.
It is down -11.80% in the last 24 hours and down -43.65% over the past month.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections in the United States. The company develops its products using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company is also developing and advancing synthetic phage for treating diseases caused by pseudomonas aeruginosa. Armata Pharmaceuticals, Inc. is headquartered in Marina del Rey, California.
See More
Previous Close:
$4.83
Open:
$4.8
24h Volume:
244.46K
Relative Volume:
2.13
Market Cap:
$156.39M
Revenue:
$5.20M
Net Income/Loss:
$-282.61M
P/E Ratio:
-0.5487
EPS:
-7.764
Net Cash Flow:
$-24.47M
1W Performance:
-27.67%
1M Performance:
-43.65%
6M Performance:
-39.57%
1Y Performance:
+87.67%
1-Day Range:
$4.16
$4.9195
1-Week Range:
$4.16
$6.2185
52-Week Range:
$2.14
$16.34
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
Name
Armata Pharmaceuticals Inc
Sector
Industry
Phone
310-655-2928
Address
4503 Glencoe Avenue, Marina del Rey, CA
Compare ARMP vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARMP
Armata Pharmaceuticals Inc
|
4.26 | 156.39M | 5.20M | -282.61M | -24.47M | -7.764 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-19-19 | Initiated | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc Stock (ARMP) Latest News
Armata Pharmaceuticals, Inc.(NYSEAM:ARMP) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 2500 Growth Benchmark - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 2000 Index - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM:ARMP) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 3000E Growth Benchmark - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 3000E Index - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM:ARMP) added to Russell Small Cap Completeness Index - marketscreener.com
Enterprise value to EBITDA forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 3000 Growth Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Armata Pharmaceuticals, Inc. – DUS:TG1N - TradingView
Price to earnings forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Price to earnings forward of Armata Pharmaceuticals, Inc. – DUS:TG1N - TradingView
Price to book forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Enterprise value to EBIT forward of Armata Pharmaceuticals, Inc. – DUS:TG1N - TradingView
Price to sales forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Price to book forward of Armata Pharmaceuticals, Inc. – BOATS:ARMP - TradingView
Enterprise value to revenue forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Enterprise value to EBITDA forward of Armata Pharmaceuticals, Inc. – BOATS:ARMP - TradingView
ARMATA PHARMACEUTICALS INC (ARMP) Stock Chart - ChartMill
ARMP Forecast — Price Target — Prediction for 2027 - TradingView
Armata Pharmaceuticals, Inc. Actuals & Estimates (DUS:TG1N) - TradingView
Armata Pharmaceuticals, Inc. Actuals & Estimates (MUN:TG1N) - TradingView
TG1N Forecast — Price Target — Prediction for 2027 - TradingView
Armata Pharmaceuticals, Inc. Appoints Daniel Gilmer to Serve on the Nominating and Corporate Governance Committee of the Board, Effective as of June 24, 2026 - marketscreener.com
Armata Pharmaceuticals Inc. (ARMP) Climbs 4.85%, Testing Resistance at $7.72Trend Reversal Picks - dars.gov.et
Armata Pharmaceuticals (ARMP) assigns Gilmer to governance committee with $5,000 retainer - Stock Titan
Armata Pharmaceuticals (ARMP) Secures $2.5M for Clinical Development - GuruFocus
Armata Pharmaceuticals stock jumps on added DoD funding - Investing.com
Form 8K Armata Pharmaceuticals Inc For: 23 June By Investing.com - Investing.com Australia
Armata receives $2.5m DoD funding for AP-SA02 development - Investing.com UK
Armata receives $2.5m DoD funding for AP-SA02 development By Investing.com - Investing.com India
Armata Pharmaceuticals Shares Rise on Additional $2.5M Government Grant - Moomoo
Armata Pharmaceuticals stock jumps on added DoD funding By Investing.com - Investing.com South Africa
Armata Pharmaceuticals Receives Additional $2.5 Million in Funding From US Department of Defense - Moomoo
Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02 - The AI Journal
Armata Pharmaceuticals Shares Rise on Additional $2.5 Million Government Grant - marketscreener.com
Armata gains new DoD funding for AP-SA02 advancement - TipRanks
Armata Pharmaceuticals Secures Additional $2.5M DoD Funding to Advance Phase 3 Phage Therapy for MRSA Infections 1 - Minichart
Armata Pharmaceuticals Inc (ARMP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Armata Pharmaceuticals Granted FDA Fast Track Designation for AP-SA02 - HarianBasis.co
Here’s Why Armata Pharmaceuticals Inc. (ARMP) is a High Growth Micro-Cap Stock to Buy? - Insider Monkey
Armata Pharmaceuticals Inc (ARMP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Armata Pharmaceuticals Inc (ARMP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Armata Pharmaceuticals Inc - TradingKey
Armata Pharmaceuticals Inc (ARMP) Institutional Confidence - TradingKey
Armata Pharmaceuticals Inc (ARMP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Armata Pharmaceuticals Inc (ARMP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Armata Pharmaceuticals Inc (ARMP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Armata Pharmaceuticals, Inc. Financial Disclosures & SEC Filings - TradingView
Armata Pharmaceuticals (ARMP) Q1 2026 Earnings: Massive EPS Miss as Pre-Revenue Biotech Faces Cost Pressures - dars.gov.et
Armata Pharmaceuticals shareholders elect board and approve executive pay at annual meeting - Investing.com Canada
Armata Pharmaceuticals Inc Stock (ARMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):